Steven R. Pacelli - Jul 23, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Managing Dir., Dexcom Ventures
Signature
By: Jereme Sylvain For: Steven R Pacelli
Stock symbol
DXCM
Transactions as of
Jul 23, 2021
Transactions value $
-$487,897
Form type
4
Date filed
7/27/2021, 06:03 PM
Previous filing
Jun 24, 2021
Next filing
Aug 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$126K -279 -0.54% $450.82 51K Jul 23, 2021 Direct F1, F2, F3
transaction DXCM Common Stock Sale -$362K -800 -1.57% $452.65 50.2K Jul 23, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 This transaction was executed in multiple trades at prices ranging from $450.70 to $450.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022.